申请人:Hoffmann-La Roche Inc.
公开号:US04742069A1
公开(公告)日:1988-05-03
Dihydropyridine derivatives of the formula ##STR1## wherein the symbols A, R and R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6 and R.sup.7 are as described herein. Compounds of formula I have a pronounced calcium-antagonistic activity and can accordingly be used as medicaments, especially for the control or prevention of angina pectoris, ischemia, high blood pressure and/or migraine.
公式I的二氢吡啶衍生物,其中符号A、R和R.sup.1、R.sup.2、R.sup.3、R.sup.4、R.sup.5、R.sup.6和R.sup.7如本文所述。公式I的化合物具有明显的钙拮抗活性,因此可用作药物,特别是用于控制或预防心绞痛、缺血、高血压和/或偏头痛。